In focus · trending topic

Alectos Therapeutics

1 stories · following the connections

Alectos Therapeutics Announces FDA Orphan Drug Designation for MK-8719: An Investigational Small-molecule OGA Inhibitor for Treatment of Progressive Supranuclear Palsy

By Nasdaq OMXApr 20, 2016, 1:00 PM UTC